Innate Pharma
IPH | PA
Overview
Corporate Details
- ISIN(s):
- FR0010331421 (+1 more)
- LEI:
- 9695002Y8420ZB8HJE29
- Country:
- France
- Address:
- 117 AVENUE DE LUMINY, 13009 MARSEILLE
- Website:
- http://www.innate-pharma.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Innate Pharma is a global, clinical-stage biotechnology company specializing in immuno-oncology. Founded in 1999 by scientific pioneers in innate immunity, the company develops first-in-class therapeutic antibodies designed to harness the immune system, particularly Natural Killer (NK) cells, to fight cancer. Its portfolio includes a pipeline of clinical-stage drug candidates and proprietary technology platforms, such as the ANKET® (Antibody-based NK cell Engager Therapeutics) platform, aimed at providing innovative treatments for cancer patients.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Innate Pharma.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-11 11:24 |
Major Shareholding Notification
Franchissements de seuils
|
French | 116.0 KB | |
| 2025-06-17 07:00 |
Investor Presentation
Informations privilégiées / Autres communiqués
|
French | 165.5 KB | |
| 2025-06-17 07:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 204.3 KB | |
| 2025-06-13 07:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 179.5 KB | |
| 2025-06-13 07:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 273.5 KB | |
| 2025-05-27 07:00 |
Report Publication Announcement
Inside Information / Other news releases
|
English | 210.2 KB | |
| 2025-05-27 07:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 173.9 KB | |
| 2025-05-23 07:00 |
Post-Annual General Meeting Information
Inside Information / Other news releases
|
English | 232.8 KB | |
| 2025-05-23 07:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 230.4 KB | |
| 2025-05-23 07:00 |
Earnings Release
Informations privilégiées / Autres communiqués
|
French | 188.7 KB | |
| 2025-05-19 07:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 181.7 KB | |
| 2025-05-19 07:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 148.3 KB | |
| 2025-05-15 07:00 |
Earnings Release
Inside Information / Other news releases
|
English | 170.4 KB | |
| 2025-05-15 07:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 123.4 KB | |
| 2025-05-13 07:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 251.1 KB |
Automate Your Workflow. Get a real-time feed of all Innate Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Innate Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-10 | N/A | Other | Buy | 6,000 | N/A |
| 2024-01-02 | N/A | Other | Buy | 20,000 | N/A |
